Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:INTTNYSEAMERICAN:KNWNASDAQ:NAUTNASDAQ:PRE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINTTinTEST$6.89-1.4%$6.27$5.24▼$11.92$86.09M1.6261,597 shs46,463 shsKNWKnow Labs$3.59-8.9%$1.12$0.33▼$23.94$29.55M0.931.54 million shs1.41 million shsNAUTNautilus Biotechnology$0.71+0.9%$0.75$0.66▼$3.09$89.31M1.43128,562 shs163,471 shsPREPrenetics Global$8.96-3.2%$6.81$3.09▼$11.99$113.02M0.1721,456 shs213,190 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINTTinTEST0.00%+1.01%+15.54%-6.92%-26.96%KNWKnow Labs0.00%-11.06%+688.00%+225.62%-83.29%NAUTNautilus Biotechnology0.00%-0.80%-13.87%-28.48%-70.62%PREPrenetics Global0.00%+15.46%+26.85%+128.08%+55.63%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINTTinTEST3.531 of 5 stars3.33.00.00.03.43.31.3KNWKnow LabsN/AN/AN/AN/AN/AN/AN/AN/ANAUTNautilus Biotechnology2.1364 of 5 stars3.02.00.00.00.64.20.6PREPrenetics Global1.0315 of 5 stars1.53.00.00.02.60.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINTTinTEST 2.67Moderate Buy$12.0074.17% UpsideKNWKnow Labs 0.00N/AN/AN/ANAUTNautilus Biotechnology 2.00Hold$2.13197.33% UpsidePREPrenetics Global 3.00Buy$9.000.45% UpsideCurrent Analyst Ratings BreakdownLatest KNW, NAUT, PRE, and INTT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/5/2025INTTinTESTNorthland CapmkSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/5/2025INTTinTESTLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$10.00 ➝ $8.00(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINTTinTEST$127.50M0.68$1.20 per share5.75$7.92 per share0.87KNWKnow Labs$4.36M6.18N/AN/A($0.80) per share-4.49NAUTNautilus BiotechnologyN/AN/AN/AN/A$1.66 per shareN/APREPrenetics Global$30.62M3.57N/AN/A$14.04 per share0.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINTTinTEST$9.34M-$0.0129.9617.23N/A2.33%5.31%3.42%N/AKNWKnow Labs-$16.58M-$0.20N/A∞N/AN/AN/A-720.15%N/ANAUTNautilus Biotechnology-$70.78M-$0.54N/AN/AN/AN/A-31.87%-27.39%7/29/2025 (Estimated)PREPrenetics Global-$46.30M-$3.99N/AN/AN/A-115.91%-28.07%-22.27%N/ALatest KNW, NAUT, PRE, and INTT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/12/2025Q1 2025PREPrenetics GlobalN/A-$0.80N/A-$0.80N/A$17.31 million5/2/2025Q1INTTinTEST-$0.10-$0.11-$0.01N/AN/AN/A4/29/2025Q1 2025NAUTNautilus Biotechnology-$0.14-$0.13+$0.01-$0.13N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINTTinTESTN/AN/AN/AN/AN/AKNWKnow LabsN/AN/AN/AN/AN/ANAUTNautilus BiotechnologyN/AN/AN/AN/AN/APREPrenetics GlobalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINTTinTEST0.082.261.38KNWKnow LabsN/A0.070.07NAUTNautilus BiotechnologyN/A17.3617.36PREPrenetics GlobalN/A2.071.89Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINTTinTEST63.18%KNWKnow Labs23.96%NAUTNautilus Biotechnology50.71%PREPrenetics Global25.01%Insider OwnershipCompanyInsider OwnershipINTTinTEST7.00%KNWKnow Labs16.20%NAUTNautilus Biotechnology41.10%PREPrenetics Global7.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINTTinTEST32012.50 million11.69 millionOptionableKNWKnow Labs207.50 million6.29 millionNot OptionableNAUTNautilus Biotechnology130126.15 million74.30 millionOptionablePREPrenetics Global112.20 million11.25 millionNot OptionableKNW, NAUT, PRE, and INTT HeadlinesRecent News About These CompaniesHealthcare Meets Crypto: David Beckham–Backed Prenetics Launches $20M Bitcoin TreasuryJune 20 at 6:43 PM | techstory.inPrenetics Global (NASDAQ:PRE) Stock, Short Interest ReportJune 19 at 6:30 PM | benzinga.comPrenetics Adopts $20M Bitcoin Treasury StrategyJune 19 at 6:31 AM | thecurrencyanalytics.comPrenetics Global First Quarter 2025 Earnings: Revenues Beat Expectations, EPS In LineJune 19 at 1:31 AM | finance.yahoo.comPrenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to BoardJune 18 at 8:45 AM | globenewswire.comPrenetics Global Limited Divests ACT Genomics, Strengthens Financial Position and Raises FY2025 Revenue OutlookJune 18 at 8:28 AM | quiverquant.comPrenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million TransactionJune 18 at 7:50 AM | globenewswire.comShort Interest in Prenetics Global Limited (NASDAQ:PRE) Increases By 46.2%June 16, 2025 | marketbeat.comPrenetics Global Limited Appoints New Independent Director to Strengthen Bitcoin StrategyJune 16, 2025 | tipranks.comEquities Analysts Set Expectations for PRE FY2026 EarningsJune 16, 2025 | americanbankingnews.comBrokers Set Expectations for PRE FY2026 EarningsJune 16, 2025 | marketbeat.comPrenetics Global reports Q1 2025 financialsJune 14, 2025 | uk.investing.comPrenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement SoonJune 14, 2025 | nasdaq.comPrenetics Global (NASDAQ:PRE) Issues Quarterly Earnings ResultsJune 12, 2025 | marketbeat.comPrenetics Global Limited (NASDAQ:PRE) Sees Large Decline in Short InterestJune 2, 2025 | marketbeat.comPrenetics Global Full Year 2024 Earnings: Misses ExpectationsMay 3, 2025 | finance.yahoo.comPrenetics Global Limited (PRENW)March 19, 2025 | ca.finance.yahoo.comPrenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements MarketMarch 18, 2025 | markets.businessinsider.comPrenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements MarketMarch 18, 2025 | globenewswire.comPrenetics to Participate in the 37th Annual ROTH ConferenceMarch 11, 2025 | finance.yahoo.comPrenetics Reports Strong 2024 Results and Optimistic 2025 OutlookMarch 5, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s Watching3 Top-Rated Energy Companies Staging Strong RecoveriesBy Nathan Reiff | June 2, 2025View 3 Top-Rated Energy Companies Staging Strong RecoveriesNVIDIA’s AI Robot Leap: 2 Stocks Set to Ride the WaveBy Nathan Reiff | May 23, 2025View NVIDIA’s AI Robot Leap: 2 Stocks Set to Ride the WaveLululemon, UNH, Enphase: Bad News, Good Opportunity?By Thomas Hughes | June 17, 2025View Lululemon, UNH, Enphase: Bad News, Good Opportunity?Chime’s Smart IPO: Half the Valuation, Double the StrengthBy Jeffrey Neal Johnson | June 18, 2025View Chime’s Smart IPO: Half the Valuation, Double the StrengthKNW, NAUT, PRE, and INTT Company DescriptionsinTEST NYSE:INTT$6.87 -0.12 (-1.66%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies. The Electronic Test segment offers in2, Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly. This segment also provides tester interfaces that offer electrical connections between the tester and the wafer prober or IC handler; scorpion flying probe test systems that designs and manufactures robotics-based electronic test equipment; and BRiZ automated test and programming services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The Environmental Technologies segment provides ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; thermal chambers; thermal platforms; Thermonics temperature conditioning products that offer tempered gas or fluid; and ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions. The Process Technologies segment offers EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey.Know Labs NYSEAMERICAN:KNW$3.59 -0.35 (-8.88%) Closing price 04:10 PM EasternExtended Trading$3.56 -0.03 (-0.84%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was incorporated in 1998 and is based in Seattle, Washington.Nautilus Biotechnology NASDAQ:NAUT$0.71 +0.01 (+0.95%) Closing price 04:00 PM EasternExtended Trading$0.71 -0.01 (-0.80%) As of 04:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.Prenetics Global NASDAQ:PRE$8.96 -0.30 (-3.24%) Closing price 04:00 PM EasternExtended Trading$8.86 -0.10 (-1.12%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
